| Lair-1 binding agents and methods for their use |
2022-12-21 |
2023-3-07 |
|
| Ilt-binding agents and methods of use thereof |
2022-10-28 |
2022-12-01 |
|
| Methods of treating cancer and tumor-related weight loss and cachexia |
2022-9-02 |
2023-3-16 |
|
| Binding proteins and methods of use thereof |
2022-8-31 |
2022-9-22 |
|
| Binding proteins and methods of use thereof |
2022-6-29 |
2022-10-12 |
|
| Methods of treating fibroblast growth factor 19-mediated cancers and tumors |
2022-6-17 |
2023-2-02 |
|
| ilt3 binding agents and methods of using the same |
2022-6-13 |
2022-8-30 |
|
| Multimerization of binding molecules having an antibody constant region variant |
2022-4-27 |
2022-11-03 |
|
| Methods for modulating bile acid homeostatsis and treatment of bile acid … |
2022-4-15 |
2022-6-01 |
|
| Htra1-binding agents and methods of use thereof |
2022-2-07 |
2022-8-11 |
|
| Methods and uses for modulating bile acid homeostasis and treatment of bile … |
2021-12-27 |
2022-8-04 |
|
| Methods for treatment of bile acid-related disorders and prediction of clinical … |
2021-9-10 |
2022-3-10 |
|
| Methods for treatment of bile acid-related disorders |
2021-8-26 |
2021-12-09 |
|
| Bama-binding agents and methods of use thereof |
2021-8-26 |
2022-3-03 |
|
| C3-binding agents and methods of use thereof |
2021-8-19 |
2022-4-21 |
|
| Methods of Using Compositions Comprising Variants and Fusions of FGF19 … |
2021-6-23 |
2022-3-24 |
|
| Pharmaceutical compositions comprising peptide variants and methods of use … |
2021-6-22 |
2022-2-17 |
|
| LAIR-1 BINDING AGENTS AND METHODS FOR THEIR USE |
2021-6-18 |
2022-9-28 |
|
| Coronavirus-binding agents and uses thereof |
2021-6-02 |
2022-3-03 |
|
| Compositions and Methods of Use for Treating Metabolic Disorders |
2021-5-26 |
2021-12-16 |
|
| Therapeutic uses of c3-binding agents |
2021-5-07 |
2021-11-11 |
|
| ILT BINDING AGENTS AND METHODS FOR THEIR USE |
2021-4-30 |
2022-7-27 |
|
| Glucagon receptor binding proteins and methods of use thereof |
2021-3-19 |
2021-10-28 |
|
| Combination therapy with glucagon receptor antagonists |
2021-2-17 |
2021-9-16 |
|
| Methods of reducing lactate in liver disease patients using variants and … |
2020-11-05 |
2021-5-14 |
|
| Cancer models and associated methods |
2020-10-07 |
2021-1-28 |
|
| Beta klotho-binding proteins |
2020-8-28 |
2021-4-22 |
|
| Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or … |
2020-8-18 |
2023-1-31 |
2023-1-31 |
| Methods of treating a wasting syndrome, increasing growth hormone levels, and … |
2020-8-14 |
2023-1-10 |
2023-1-10 |
| Compositions and Methods for Treatment of Metabolic Disorders and Diseases |
2020-8-10 |
2021-6-10 |
|
| Angiopoietin-like protein 8 polypeptide fragments and compositions thereof |
2020-5-29 |
2021-1-21 |
|
| Combination Therapy for Modulating Bile Acid Homeostasis and Treatment of Bile … |
2020-4-16 |
2020-12-17 |
|
| Non-invasive biomarkers for use in the treatment of non-alcoholic … |
2020-2-27 |
2020-9-03 |
|
| Compositions and methods of use for treating metabolic disorders |
2020-2-07 |
2022-6-14 |
2022-6-14 |
| Compositions and methods of use for treating metabolic disorders |
2020-1-15 |
2022-12-20 |
2022-12-20 |
| B7-h7-binding agents and methods of use thereof |
2019-8-20 |
2021-7-21 |
|
| Methods and Compositions for the Treatment of Metabolic Disorders and Diseases |
2019-8-06 |
2020-2-20 |
|
| Bispecific antibodies |
2019-7-02 |
2021-3-23 |
|
| Bispecific antibodies |
2019-3-15 |
2019-9-19 |
|
| Methods of Using Compositions Comprising Variants and Fusions of FGF19 … |
2019-2-21 |
2019-6-13 |
|
| Compositions and methods of use for treating metabolic disorders |
2018-12-14 |
2020-12-22 |
2020-12-22 |
| Compositions comprising variants and fusions of FGF19 polypeptides |
2018-12-11 |
2021-7-20 |
2021-7-20 |
| Compositions and methods for modulating body weight |
2018-8-27 |
2018-10-31 |
|
| Methods of treating gastrointestinal motility -related disorders using variants … |
2018-4-20 |
2018-10-25 |
|
| Compositions and methods of use for treating metabolic disorders |
2017-10-20 |
2018-4-12 |
|
| Methods for treatment of bile acid-related disorders |
2017-8-28 |
2019-3-07 |
|
| Binding proteins and methods of use thereof |
2017-3-03 |
2022-3-25 |
|
| COMPLEX THAT INCLUDES A POLYPEPTIDE CITOSINA-1 MACROPHAGUS INHIBITOR (MIC-1) … |
2015-10-29 |
2017-3-01 |
|
| COMPOSITIONS THAT INCLUDE THE GROWTH FACTOR POLYPEPTIDE 15 (GDF15) OR … |
2015-7-29 |
2016-12-14 |
|
| Compositions and methods for targeting a pathway |
2015-5-19 |
2017-11-01 |
|
| Methods of treating glucose metabolism disorders |
2013-7-15 |
2014-1-23 |
|
| Methods of treating glucose metabolism disorders |
2013-7-15 |
2014-1-23 |
|
| Methods of treating glucose metabolism disorders |
2013-2-20 |
2013-10-10 |
|
| Methods of Treating Glucose Metabolism Disorders and Promoting Weight Loss |
2012-12-14 |
2013-8-22 |
|
| Methods of Treating Glucose Metabolism Disorders |
2012-12-14 |
2013-8-22 |
|
| Compositions, uses and methods for treatment of metabolic disorders and … |
2012-6-29 |
2016-11-01 |
|